“…The most suitable ligands for the tight binding of Ln(III) ions are highly rigid macrocyclic compounds which fulfil the above-mentioned properties due to the macrocyclic effect [ 17 , 18 , 19 ]. When the coordination number of the Ln(III) ion (usually about 8–9) is equal to denticity of macrocyclic ligand, complexes with 1:1 stoichiometry are formed [ 5 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 ]. For these reasons, Ln(III) complexes with macrocyclic ligands (mainly DOTA derivatives) are commonly utilized in medicinal chemistry as radiopharmaceuticals ( 90 Y, 153 Sm, 166 Ho, 177 Lu) [ 18 , 25 ] and contrast agents for MRI (Gd) [ 5 , 18 , 26 , 27 ].…”